nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pons—Parkinson's disease	0.0452	0.156	CbGeAlD
Nedocromil—CYSLTR2—cardiovascular system—Parkinson's disease	0.0251	0.0866	CbGeAlD
Nedocromil—HSP90AA1—hindbrain—Parkinson's disease	0.0176	0.0605	CbGeAlD
Nedocromil—FPR1—head—Parkinson's disease	0.0153	0.0528	CbGeAlD
Nedocromil—FPR1—nervous system—Parkinson's disease	0.0145	0.0501	CbGeAlD
Nedocromil—PTGDR—head—Parkinson's disease	0.0145	0.0499	CbGeAlD
Nedocromil—FPR1—central nervous system—Parkinson's disease	0.014	0.0482	CbGeAlD
Nedocromil—PTGDR—nervous system—Parkinson's disease	0.0137	0.0473	CbGeAlD
Nedocromil—PTGDR—central nervous system—Parkinson's disease	0.0132	0.0455	CbGeAlD
Nedocromil—HSP90AA1—embryo—Parkinson's disease	0.011	0.0378	CbGeAlD
Nedocromil—PTGDR—brain—Parkinson's disease	0.0105	0.0362	CbGeAlD
Nedocromil—HSP90AA1—brainstem—Parkinson's disease	0.0101	0.0347	CbGeAlD
Nedocromil—HSP90AA1—forebrain—Parkinson's disease	0.00971	0.0335	CbGeAlD
Nedocromil—HSP90AA1—cardiovascular system—Parkinson's disease	0.00821	0.0283	CbGeAlD
Nedocromil—HSP90AA1—medulla oblongata—Parkinson's disease	0.00702	0.0242	CbGeAlD
Nedocromil—HSP90AA1—midbrain—Parkinson's disease	0.00641	0.0221	CbGeAlD
Nedocromil—CYSLTR1—head—Parkinson's disease	0.00641	0.0221	CbGeAlD
Nedocromil—HSP90AA1—spinal cord—Parkinson's disease	0.00626	0.0216	CbGeAlD
Nedocromil—CYSLTR1—nervous system—Parkinson's disease	0.00608	0.0209	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—Parkinson's disease	0.00585	0.0202	CbGeAlD
Nedocromil—HSP90AA1—head—Parkinson's disease	0.00556	0.0192	CbGeAlD
Nedocromil—HSP90AA1—nervous system—Parkinson's disease	0.00527	0.0182	CbGeAlD
Nedocromil—HSP90AA1—central nervous system—Parkinson's disease	0.00508	0.0175	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—Parkinson's disease	0.00496	0.0171	CbGeAlD
Nedocromil—CYSLTR1—brain—Parkinson's disease	0.00464	0.016	CbGeAlD
Nedocromil—HSP90AA1—brain—Parkinson's disease	0.00403	0.0139	CbGeAlD
Nedocromil—CYSLTR1—Signaling by GPCR—GRM5—Parkinson's disease	0.000464	0.000654	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD3—Parkinson's disease	0.000462	0.000651	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—GPX1—Parkinson's disease	0.000462	0.000651	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—HTR7—Parkinson's disease	0.00046	0.000648	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—DRD2—Parkinson's disease	0.00046	0.000648	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—FGF20—Parkinson's disease	0.000458	0.000646	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000458	0.000645	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—FGF20—Parkinson's disease	0.000458	0.000645	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TALDO1—Parkinson's disease	0.000453	0.000639	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—OMD—Parkinson's disease	0.000453	0.000639	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—EDN1—Parkinson's disease	0.000452	0.000637	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000444	0.000625	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—FGF20—Parkinson's disease	0.000442	0.000623	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EDN1—Parkinson's disease	0.000442	0.000622	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TAF1—Parkinson's disease	0.000436	0.000615	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FBP1—Parkinson's disease	0.000436	0.000615	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ABL1—Parkinson's disease	0.000436	0.000614	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000435	0.000612	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VPS35—Parkinson's disease	0.000434	0.000611	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000432	0.000608	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NDUFB11—Parkinson's disease	0.00043	0.000605	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADORA2A—Parkinson's disease	0.000429	0.000604	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—TNF—Parkinson's disease	0.000427	0.000601	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EDN1—Parkinson's disease	0.000426	0.000601	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PDYN—Parkinson's disease	0.000426	0.0006	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000425	0.000599	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—DRD2—Parkinson's disease	0.000418	0.000589	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HTR7—Parkinson's disease	0.000418	0.000589	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HSPA8—Parkinson's disease	0.000416	0.000586	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000411	0.000579	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GCH1—Parkinson's disease	0.00041	0.000577	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—INSR—Parkinson's disease	0.00041	0.000577	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RIT2—Parkinson's disease	0.0004	0.000564	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GFAP—Parkinson's disease	0.0004	0.000564	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—INSR—Parkinson's disease	0.000396	0.000557	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GRM5—Parkinson's disease	0.000396	0.000557	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000395	0.000557	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000395	0.000556	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—DLG4—Parkinson's disease	0.00039	0.00055	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—FGB—Parkinson's disease	0.000387	0.000545	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000386	0.000544	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000385	0.000543	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—GRIN2B—Parkinson's disease	0.000381	0.000537	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GRK5—Parkinson's disease	0.000379	0.000534	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TAC1—Parkinson's disease	0.000379	0.000534	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.000378	0.000532	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000377	0.000531	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—FGB—Parkinson's disease	0.000374	0.000527	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HTR2A—Parkinson's disease	0.000373	0.000526	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD1—Parkinson's disease	0.000372	0.000524	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HTR1A—Parkinson's disease	0.000372	0.000524	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000371	0.000523	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000369	0.000519	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TAC1—Parkinson's disease	0.000366	0.000516	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—DBH—Parkinson's disease	0.000365	0.000515	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—FBP1—Parkinson's disease	0.000365	0.000515	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GBA—Parkinson's disease	0.000365	0.000515	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000364	0.000513	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD3—Parkinson's disease	0.00036	0.000508	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GPR37—Parkinson's disease	0.000359	0.000506	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DGKQ—Parkinson's disease	0.000359	0.000506	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD1—Parkinson's disease	0.000359	0.000506	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000353	0.000497	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000351	0.000495	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SNCA—Parkinson's disease	0.000349	0.000491	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RPL6—Parkinson's disease	0.000349	0.000491	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD3—Parkinson's disease	0.000348	0.00049	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGF20—Parkinson's disease	0.000347	0.000489	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—IL6—Parkinson's disease	0.000344	0.000485	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000343	0.000483	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GRM4—Parkinson's disease	0.00034	0.000479	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TAC1—Parkinson's disease	0.000337	0.000475	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ADRBK1—Parkinson's disease	0.000337	0.000475	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000336	0.000474	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000336	0.000474	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EDN1—Parkinson's disease	0.000335	0.000471	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD1—Parkinson's disease	0.000331	0.000466	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000329	0.000464	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000329	0.000463	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—DCTN1—Parkinson's disease	0.000328	0.000461	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HTR7—Parkinson's disease	0.000326	0.000459	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—DRD2—Parkinson's disease	0.000326	0.000459	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADRBK1—Parkinson's disease	0.000325	0.000458	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PENK—Parkinson's disease	0.000323	0.000454	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAG—Parkinson's disease	0.000323	0.000454	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000322	0.000454	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD3—Parkinson's disease	0.00032	0.000451	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000319	0.000449	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000319	0.000449	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—DRD2—Parkinson's disease	0.000315	0.000443	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HTR7—Parkinson's disease	0.000315	0.000443	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ABL1—Parkinson's disease	0.000311	0.000438	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—INSR—Parkinson's disease	0.00031	0.000437	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—Parkinson's disease	0.000305	0.00043	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000299	0.000421	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-DRA—Parkinson's disease	0.000298	0.00042	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDYN—Parkinson's disease	0.000295	0.000416	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PLA2G6—Parkinson's disease	0.000295	0.000415	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGB—Parkinson's disease	0.000293	0.000413	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000293	0.000412	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR1A—Parkinson's disease	0.000292	0.000411	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—DRD2—Parkinson's disease	0.00029	0.000408	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR7—Parkinson's disease	0.00029	0.000408	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—IL6—Parkinson's disease	0.000288	0.000406	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TAC1—Parkinson's disease	0.000287	0.000405	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RIT2—Parkinson's disease	0.000287	0.000405	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD1—Parkinson's disease	0.000282	0.000397	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GFAP—Parkinson's disease	0.000277	0.000391	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ABL1—Parkinson's disease	0.000275	0.000387	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GRM5—Parkinson's disease	0.000274	0.000386	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF2—Parkinson's disease	0.000273	0.000385	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD3—Parkinson's disease	0.000273	0.000385	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GRK5—Parkinson's disease	0.000272	0.000384	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PARK2—Parkinson's disease	0.000269	0.000379	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—DDC—Parkinson's disease	0.000268	0.000378	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FGF20—Parkinson's disease	0.000267	0.000376	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RPL23A—Parkinson's disease	0.000264	0.000372	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RPL14—Parkinson's disease	0.000264	0.000372	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000264	0.000372	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF2—Parkinson's disease	0.000264	0.000372	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EDN1—Parkinson's disease	0.000261	0.000367	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000255	0.00036	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000255	0.000359	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF1R—Parkinson's disease	0.000255	0.000359	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTA4—Parkinson's disease	0.000253	0.000357	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EDN1—Parkinson's disease	0.000252	0.000355	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DRD2—Parkinson's disease	0.000247	0.000348	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR7—Parkinson's disease	0.000247	0.000348	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGF20—Parkinson's disease	0.000246	0.000347	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RPS8—Parkinson's disease	0.000246	0.000347	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GRM4—Parkinson's disease	0.000244	0.000344	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000243	0.000343	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGF20—Parkinson's disease	0.00024	0.000339	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NGF—Parkinson's disease	0.00024	0.000338	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000233	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—MAPK8—Parkinson's disease	0.000232	0.000327	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EDN1—Parkinson's disease	0.000232	0.000327	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NGF—Parkinson's disease	0.000232	0.000326	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAG—Parkinson's disease	0.000232	0.000326	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PENK—Parkinson's disease	0.000232	0.000326	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HTR2A—Parkinson's disease	0.000228	0.000321	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PLA2G6—Parkinson's disease	0.000228	0.000321	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MAOB—Parkinson's disease	0.000226	0.000318	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000223	0.000315	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HTR2A—Parkinson's disease	0.00022	0.00031	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—IL6—Parkinson's disease	0.000218	0.000307	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—INSR—Parkinson's disease	0.000215	0.000303	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—APOE—Parkinson's disease	0.000212	0.000299	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDYN—Parkinson's disease	0.000212	0.000298	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF2—Parkinson's disease	0.000207	0.000292	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—INS—Parkinson's disease	0.000205	0.000289	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—APOE—Parkinson's disease	0.000205	0.000289	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGB—Parkinson's disease	0.000203	0.000287	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000203	0.000286	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000202	0.000285	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.0002	0.000282	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1R—Parkinson's disease	0.0002	0.000282	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TAC1—Parkinson's disease	0.000199	0.000281	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GFAP—Parkinson's disease	0.000199	0.00028	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EDN1—Parkinson's disease	0.000198	0.000279	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GRM5—Parkinson's disease	0.000197	0.000277	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ADRBK1—Parkinson's disease	0.000196	0.000276	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD1—Parkinson's disease	0.000195	0.000275	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD3—Parkinson's disease	0.000189	0.000267	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NGF—Parkinson's disease	0.000182	0.000256	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—INS—Parkinson's disease	0.000181	0.000255	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ADRBK1—Parkinson's disease	0.000181	0.000255	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HSPA1A—Parkinson's disease	0.00018	0.000253	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000177	0.000249	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—INS—Parkinson's disease	0.000175	0.000247	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR2A—Parkinson's disease	0.000173	0.000244	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGF20—Parkinson's disease	0.000173	0.000243	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DRD2—Parkinson's disease	0.000171	0.000241	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR7—Parkinson's disease	0.000171	0.000241	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP2D6—Parkinson's disease	0.000168	0.000236	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000167	0.000236	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CTGF—Parkinson's disease	0.000165	0.000232	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APOE—Parkinson's disease	0.000161	0.000227	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ABL1—Parkinson's disease	0.00016	0.000225	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—INSR—Parkinson's disease	0.000154	0.000218	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP2E1—Parkinson's disease	0.000153	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NQO1—Parkinson's disease	0.000152	0.000214	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HGF—Parkinson's disease	0.00015	0.000212	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TH—Parkinson's disease	0.00015	0.000211	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—Parkinson's disease	0.000148	0.000209	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGB—Parkinson's disease	0.000146	0.000206	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR1A—Parkinson's disease	0.000145	0.000205	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYCS—Parkinson's disease	0.000144	0.000202	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF2—Parkinson's disease	0.000143	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TAC1—Parkinson's disease	0.000143	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD1—Parkinson's disease	0.00014	0.000198	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000139	0.000195	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—INS—Parkinson's disease	0.000137	0.000194	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EDN1—Parkinson's disease	0.000137	0.000193	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD3—Parkinson's disease	0.000136	0.000191	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CASP3—Parkinson's disease	0.000135	0.00019	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—Parkinson's disease	0.000134	0.000189	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CASP3—Parkinson's disease	0.00013	0.000184	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—Parkinson's disease	0.000129	0.000182	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—COMT—Parkinson's disease	0.000127	0.000179	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000127	0.000179	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTP1—Parkinson's disease	0.000127	0.000178	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MAOA—Parkinson's disease	0.000126	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NGF—Parkinson's disease	0.000126	0.000177	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—Parkinson's disease	0.000126	0.000177	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—Parkinson's disease	0.000125	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK8—Parkinson's disease	0.000124	0.000175	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK8—Parkinson's disease	0.000124	0.000175	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR7—Parkinson's disease	0.000123	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD2—Parkinson's disease	0.000123	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTHFR—Parkinson's disease	0.000123	0.000173	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—Parkinson's disease	0.00012	0.000169	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK8—Parkinson's disease	0.00012	0.000169	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCB1—Parkinson's disease	0.00012	0.000169	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTM1—Parkinson's disease	0.000116	0.000164	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOE—Parkinson's disease	0.000114	0.000161	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOE—Parkinson's disease	0.000111	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—Parkinson's disease	0.000111	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—Parkinson's disease	0.000111	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF2—Parkinson's disease	0.000103	0.000145	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MTHFR—Parkinson's disease	0.000103	0.000145	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CASP3—Parkinson's disease	0.000102	0.000144	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—Parkinson's disease	0.000102	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1R—Parkinson's disease	9.95e-05	0.00014	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EDN1—Parkinson's disease	9.84e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—INS—Parkinson's disease	9.76e-05	0.000137	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOE—Parkinson's disease	9.57e-05	0.000135	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—INS—Parkinson's disease	9.52e-05	0.000134	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK8—Parkinson's disease	9.4e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NGF—Parkinson's disease	9.04e-05	0.000127	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—Parkinson's disease	8.98e-05	0.000126	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—Parkinson's disease	8.6e-05	0.000121	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—INS—Parkinson's disease	8.17e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOE—Parkinson's disease	8e-05	0.000113	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—Parkinson's disease	7.93e-05	0.000112	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—Parkinson's disease	7.92e-05	0.000112	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—Parkinson's disease	7.89e-05	0.000111	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—Parkinson's disease	7.65e-05	0.000108	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK8—Parkinson's disease	7.23e-05	0.000102	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CASP3—Parkinson's disease	7.09e-05	9.99e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—Parkinson's disease	7.04e-05	9.92e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—INS—Parkinson's disease	6.83e-05	9.63e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK8—Parkinson's disease	6.51e-05	9.18e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—Parkinson's disease	6e-05	8.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CASP3—Parkinson's disease	5.09e-05	7.17e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK8—Parkinson's disease	4.68e-05	6.59e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—Parkinson's disease	4.62e-05	6.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—Parkinson's disease	4.26e-05	6.01e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—Parkinson's disease	4.16e-05	5.86e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—Parkinson's disease	2.99e-05	4.21e-05	CbGpPWpGaD
